| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.74B | 11.59B | 13.12B | 15.41B | 18.44B | 18.16B |
| Gross Profit | 5.68B | 4.26B | 6.10B | 7.27B | 8.71B | 8.50B |
| EBITDA | -1.22B | -2.56B | -1.09B | -731.00M | -582.00M | -811.00M |
| Net Income | -1.48B | -3.08B | -1.47B | -1.15B | -1.06B | -1.31B |
Balance Sheet | ||||||
| Total Assets | 9.62B | 7.09B | 7.31B | 8.38B | 10.76B | 11.95B |
| Cash, Cash Equivalents and Short-Term Investments | 4.07B | 1.76B | 1.96B | 1.54B | 2.71B | 4.08B |
| Total Debt | 909.00M | 913.00M | 928.00M | 19.00M | 31.00M | 42.00M |
| Total Liabilities | 5.49B | 5.29B | 6.07B | 5.66B | 6.89B | 7.03B |
| Stockholders Equity | 4.13B | 1.80B | 1.23B | 2.71B | 3.86B | 4.92B |
Cash Flow | ||||||
| Free Cash Flow | -804.00M | -4.07B | -587.00M | -1.26B | -1.36B | -897.00M |
| Operating Cash Flow | -801.50M | -4.07B | -548.00M | -1.21B | -1.25B | -750.00M |
| Investing Cash Flow | -21.00M | 236.00M | 80.00M | 54.00M | -108.00M | -128.00M |
| Financing Cash Flow | 1.74B | 3.62B | 888.00M | -11.00M | -11.00M | -76.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥656.68B | 12.84 | 12.11% | 2.68% | 1.73% | 2.18% | |
77 Outperform | ¥22.42T | 40.16 | 19.84% | 0.90% | 11.25% | 16.84% | |
75 Outperform | ¥591.68B | 24.70 | ― | 1.04% | 17.47% | 22.05% | |
73 Outperform | ¥704.01B | 20.92 | 8.48% | 2.02% | 5.20% | 6.54% | |
72 Outperform | ¥40.24B | -29.01 | ― | 3.62% | -3.00% | -23.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
42 Neutral | ¥5.95B | -0.47 | ― | ― | -11.65% | -43.31% |